missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human VSTM2B Fc Chimera Protein
Description
Measured by its ability to inhibit anti-CD3 antibody induced IFN-gamma secretion by human peripheral blood mononuclear cells (PBMC). The ED50 for this effect is 1.5-7.5 μg/mL.
Specifications
Specifications
| Accession Number | A6NLU5 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Molecular Weight (g/mol) | M.W. (Observed): 62-70 kDa, reducing conditions; M.W. (theoretical): 51 kDa |
| Purification Method | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining |
| Quantity | 50 μg |
| Source | Human embryonic kidney cell, HEK293-derived human VSTM2B protein Human VSTM2B (Ala29-Thr263) (N-terminus) Accession # A6NLU5 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Gene Alias | V-set and transmembrane domain-containing protein 2 B |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?